4D Molecular Therapeutics, Inc. (FDMT)
9.72
-0.19
(-1.92%)
USD |
NASDAQ |
Jun 01, 16:00
9.71
-0.01
(-0.10%)
After-Hours: 20:00
4D Molecular Therapeutics Market Cap : 508.13M for June 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Perspective Therapeutics, Inc. | 417.41M |
| Agenus, Inc. | 144.50M |
| Amgen, Inc. | 177.67B |
| Anika Therapeutics, Inc. | 194.26M |
| BioCryst Pharmaceuticals, Inc. | 2.179B |
Market Cap Related Metrics
| PS Ratio | 6.546 |
| Price to Book Value | 1.125 |
| Price | 9.72 |
| Earnings Yield | -27.41% |